ResolutionRx Ltd

About ResolutionRx Ltd

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative and revolutionary treatments for disorders caused by the disruption of neuronal signaling.

Products & Services

ResolutionRx - Pharmaceutical Cannabinoids:A platform focusing on pharmaceutical cannabinoids, including treatments like Dronabinol for Obstructive Sleep Apnea.

EndeavourRx - Neuromodulators:A platform for neuromodulators, including Ampakines for conditions like ADHD and Spinal Cord Injury, and GABAkines for epilepsy and pain management.

Specialties

Pharmaceutical Cannabinoids Neuromodulators Ampakines for ADHD and Spinal Cord Injury GABAkines for Epilepsy and Pain Management Obstructive Sleep Apnea Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 45000000 MR: - FA: up to $45 million FAN: 45000000	D: 2025-11-18 FD: 2025-11-18	-
2	RT: Debt T: - FT: Debt	A: 16500000 MR: - FA: Up to 80% of anticipated R&D tax refund on a US$16.5 million budget FAN: 16500000	D: 2023-01-27 FD: 2023-01-27	1 investors

Private Placement Latest

2025-11-18

$45.0M

Debt 2023-01-27

$16.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Arnold S. Lippa

Chief Scientific Officer, Executive Chairman of Board of Directors

R

Richard Purcell

Senior Vice President Research & Development

D

David Dickason

Senior Vice-President Preclinical Product Development

J

James Cook

Research Fellow and Scientific Advisor

J

Jeffrey M. Witkin

Research Fellow and Scientific Advisor

R

Rok Cerne

Senior Research Scientist

View 4 more team members with Pro

Unlock Full Team Directory

Recent News